South African Medical News

Back to Home Page

Print using browser
Boehringer Ingelheim discontinue Inflanaze 50 Aqueous Nasal Spray (budesonide)

boehringeringelheimlogo






Dear Healthcare Provider

Boehringer Ingelheim regrets to inform you that INFLANAZE 50 Aqueous Nasal Spray has been discontinued and will no longer be manufactured.

Boehringer Ingelheim apologise in advance for any inconvenience caused by this discontinuation.

* This is a drug - read the leaflet carefully before use. 


* Ask your doctor or pharmacist for further information. 


For full prescribing information please refer to package insert approved by the Medical Regulatory Authority.
 
Ingelheim Pharmaceuticals (Pty) Ltd, 407 Pine Ave, Randburg

S3 Inflanaze 50 Aqueous nasal spray. Each metered dose contains 50µg micronised budesonide. Reg. No. 32/21.5.1/0532.

You need to be logged in to see more details. Register Now!


Click here to visit the Boehringer Ingelheim website....
Contact: Francesco Martiradonna, National Key Accounts Manager
Telephone: +27 (0) 11 348 2400
E-mail: francesco.martiradonna@boehringer-ingelheim.com
Date: Wednesday, August 23, 2017